LAB FY 2023 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$106M+8.6% YoY

Gross Profit

$50M47.4% margin

Operating Income

-$77M-72.0% margin

Net Income

-$75M-70.2% margin

EPS (Diluted)

$-0.94

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$46M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$323M

Total Liabilities

$471M

Stockholders' Equity

-$148M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$98M	+8.6%
Gross Profit	$50M	$37M	+36.2%
Operating Income	-$77M	-$116M	+34.1%
Net Income	-$75M	-$190M	+60.7%